A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease
- PMID: 27899037
- DOI: 10.1080/1354750X.2016.1265003
A comparison of HMGB1 concentrations between cerebrospinal fluid and blood in patients with neurological disease
Abstract
Aims: To determine whether a correlation exists between paired cerebrospinal fluid (CSF) and serum levels of a novel inflammatory biomarker, high-mobility group box 1 (HMGB1), in different neurological conditions.
Methods: HMGB1 was measured in the serum and CSF of 46 neurological patients (18 idiopathic intracranial hypertension [IIH], 18 neurological infection/inflammation [NII] and 10 Rasmussen's encephalitis [RE]).
Results: Mean serum (± SD) HMGB1 levels were 1.43 ± 0.54, 25.28 ± 27.9 and 1.89 ± 1.49 ng/ml for the patients with IIH, NII and RE, respectively. Corresponding mean (± SD) CSF levels were 0.35 ± 0.22, 4.48 ± 6.56 and 2.24 ± 2.35 ng/ml. Both CSF and serum HMGB1 was elevated in NII. Elevated CSF HMGB1 was demonstrated in RE. There was no direct correlation between CSF and serum levels of HMGB1.
Conclusion: Serum HMGB1 cannot be used as a surrogate measure for CSF levels. CSF HMGB1 was elevated in NII and RE, its role as a prognostic/stratification biomarker needs further study.
Keywords: High-mobility group box 1 (HMGB1); biomarker; cerebrospinal fluid.
Similar articles
-
CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.J Neurol Neurosurg Psychiatry. 2013 May;84(5):517-22. doi: 10.1136/jnnp-2012-304039. Epub 2012 Dec 19. J Neurol Neurosurg Psychiatry. 2013. PMID: 23255728
-
High mobility group box 1 in cerebrospinal fluid from several neurological diseases at early time points.Int J Neurosci. 2011 Aug;121(8):480-4. doi: 10.3109/00207454.2011.580868. Epub 2011 Jun 10. Int J Neurosci. 2011. PMID: 21663379
-
The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.Acta Neurol Scand. 2018 Feb;137(2):277-282. doi: 10.1111/ane.12850. Epub 2017 Oct 12. Acta Neurol Scand. 2018. PMID: 29023630
-
[Novel therapeutic target in neuromyelitis optica and multiple sclerosis: high mobility group box 1 (HMGB1)].Rinsho Shinkeigaku. 2014;54(12):975-7. doi: 10.5692/clinicalneurol.54.975. Rinsho Shinkeigaku. 2014. PMID: 25672684 Review. Japanese.
-
Neurofilament light chain as a biomarker in neurological disorders.J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870-881. doi: 10.1136/jnnp-2018-320106. Epub 2019 Apr 9. J Neurol Neurosurg Psychiatry. 2019. PMID: 30967444 Review.
Cited by 4 articles
-
Evaluation of serum high-mobility group box 1 concentration in dogs with epilepsy: A case-control study.J Vet Intern Med. 2020 Nov;34(6):2545-2554. doi: 10.1111/jvim.15940. Epub 2020 Nov 5. J Vet Intern Med. 2020. PMID: 33150666 Free PMC article.
-
Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome.Neuropsychopharmacology. 2020 Jul;45(8):1323-1329. doi: 10.1038/s41386-020-0671-6. Epub 2020 Apr 9. Neuropsychopharmacology. 2020. PMID: 32272483 Free PMC article.
-
Detrimental Effects of HMGB-1 Require Microglial-Astroglial Interaction: Implications for the Status Epilepticus -Induced Neuroinflammation.Front Cell Neurosci. 2019 Aug 27;13:380. doi: 10.3389/fncel.2019.00380. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31507379 Free PMC article.
-
AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.Mol Cell Biochem. 2019 Sep;459(1-2):95-112. doi: 10.1007/s11010-019-03553-4. Epub 2019 May 11. Mol Cell Biochem. 2019. PMID: 31079281 Review.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
